Activities of Trovafloxacin and Ampicillin-Sulbactam Alone or in Combination versus Three Strains of Vancomycin- Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

The recent isolation of clinical strains of methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility (MICs, 8 μg/ml) to vancomycin (vancomycin-intermediate S. aureus [VISA]) emphasizes the importance of developing novel antimicrobial regimens and/or agents for future treat...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Aeschlimann, Jeffrey R., Hershberger, Ellie, Rybak, Michael J.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2000
Schlagworte:	Experimental Therapeutics
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89837/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770744/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1153-1158.2000
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!